Tarek Hussein
About
In The Last Decade
Tarek Hussein
24 papers receiving 471 citations
Peers
Comparison fields: 5 of 84
- Pharmacology 240
- Psychiatry and Mental health 106
- Pathology and Forensic Medicine 90
- Orthopedics and Sports Medicine 61
- Physical Therapy, Sports Therapy and Rehabilitation 60
Countries citing papers authored by Tarek Hussein
This map shows the geographic impact of Tarek Hussein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tarek Hussein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tarek Hussein more than expected).
Fields of papers citing papers by Tarek Hussein
This network shows the impact of papers produced by Tarek Hussein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tarek Hussein. The network helps show where Tarek Hussein may publish in the future.
Co-authorship network of co-authors of Tarek Hussein
This figure shows the co-authorship network connecting the top 25 collaborators of Tarek Hussein. A scholar is included among the top collaborators of Tarek Hussein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tarek Hussein. Tarek Hussein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 2 | |
| 4 | 9 | |
| 5 | 11 | |
| 6 | 2 | |
| 7 | 4 | |
| 8 | 25 | |
| 9 | 16 | |
| 10 | 15 | |
| 11 | 2 | |
| 12 | 7 | |
| 13 | 17 | |
| 14 | 5 | |
| 15 | 18 | |
| 16 | 1 | |
| 17 | 9 | |
| 18 | Concurrent cisplatin/radiation followed by adjuvant cisplatin/paclitaxel in treatment of patients with stage IB grade 3, IC and IIA endometrial carcinoma. | 3 |
| 19 | A profile of tumor markers in the population of Kuwait. | 4 |
| 20 | 298 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.